Seeing Is Believing
Currently out of the existing stock ratings of Anne Samuel, 60 are a BUY (55.56%), 40 are a HOLD (37.04%), 8 are a SELL (7.41%).
Analyst Anne Samuel, currently employed at JPMORGAN, carries an average stock price target met ratio of 67.03% that have a potential upside of 16.9% achieved within 244 days.
Anne Samuel’s has documented 227 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on EVH, Evolent Health at 17-Nov-2025.
Analyst best performing recommendations are on OMCL (OMNICELL).
The best stock recommendation documented was for OMCL (OMNICELL) at 11/20/2024. The price target of $44 was fulfilled within 1 day with a profit of $2.18 (5.21%) receiving and performance score of 52.13.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 22-Apr-2024
$9.5
$5.61 (144.22%)
$18
1 months 16 days ago
(21-Nov-2025)
0/5 (0%)
$5.81 (157.45%)
Buy
Since 06-Jan-2016
$9
$5.11 (131.36%)
$16
1 months 20 days ago
(17-Nov-2025)
16/30 (53.33%)
$4.55 (102.25%)
492
Buy
Since 18-Nov-2021
$7
$3.11 (79.95%)
$13
1 months 20 days ago
(17-Nov-2025)
4/13 (30.77%)
$2.55 (57.30%)
105
Buy
Since 26-Jul-2016
$7
$3.11 (79.95%)
$7
1 months 20 days ago
(17-Nov-2025)
5/16 (31.25%)
$2.55 (57.30%)
788
Buy
Since 06-Dec-2023
$11
$7.11 (182.78%)
$13
1 months 27 days ago
(10-Nov-2025)
1/10 (10%)
$6.05 (122.22%)
13
Which stock is Anne Samuel is most bullish on?
Which stock is Anne Samuel is most reserved on?
What Year was the first public recommendation made by Anne Samuel?